BRPI0817031A2 - kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos - Google Patents

kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos

Info

Publication number
BRPI0817031A2
BRPI0817031A2 BRPI0817031A BRPI0817031A BRPI0817031A2 BR PI0817031 A2 BRPI0817031 A2 BR PI0817031A2 BR PI0817031 A BRPI0817031 A BR PI0817031A BR PI0817031 A BRPI0817031 A BR PI0817031A BR PI0817031 A2 BRPI0817031 A2 BR PI0817031A2
Authority
BR
Brazil
Prior art keywords
diagnostic kit
mammalian subjects
cancer prognosis
prognosis
cancer
Prior art date
Application number
BRPI0817031A
Other languages
English (en)
Inventor
Haibe-Kains Benjamin
Desmedt Christine
Sotiriou Christos
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of BRPI0817031A2 publication Critical patent/BRPI0817031A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
BRPI0817031A 2007-09-07 2008-09-05 kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos BRPI0817031A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97078207P 2007-09-07 2007-09-07
PCT/EP2008/061827 WO2009049966A2 (en) 2007-09-07 2008-09-05 Methods and tools for prognosis of cancer in her2+ patients

Publications (1)

Publication Number Publication Date
BRPI0817031A2 true BRPI0817031A2 (pt) 2017-05-23

Family

ID=40380075

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817031A BRPI0817031A2 (pt) 2007-09-07 2008-09-05 kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos

Country Status (7)

Country Link
US (1) US20110306507A1 (pt)
EP (1) EP2188385A2 (pt)
JP (1) JP2010537658A (pt)
AU (1) AU2008314009A1 (pt)
BR (1) BRPI0817031A2 (pt)
CA (1) CA2695814A1 (pt)
WO (1) WO2009049966A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
CA2804626C (en) 2010-07-27 2020-07-28 Genomic Health, Inc. Method for using expression of glutathione s-transferase mu 2 (gstm2) to determine prognosis of prostate cancer
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
JP2021500566A (ja) * 2017-10-24 2021-01-07 ユニヴェルシテ パリ デカルトＵｎｉｖｅｒｓｉｔｅ Ｐａｒｉｓ Ｄｅｓｃａｒｔｅｓ モエシンをバイオマーカーとして使用するｈｅｒ２依存性がんの診断及び／又は予後
CN113025716A (zh) * 2021-03-02 2021-06-25 北京大学第一医院 一种用于人肿瘤分级的基因组合及其用途
CN114250302B (zh) * 2021-12-23 2022-08-19 首都医科大学附属北京佑安医院 用于宫颈上皮内瘤变检测的组合物、试剂盒及用途
CN115449555B (zh) * 2022-10-26 2023-10-13 山东大学 Adgra2作为乳腺癌化疗疗效和预后评价生物标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004015626D1 (de) * 2003-08-28 2008-09-18 Ipsogen Bei brustkrebs
GB0323225D0 (en) * 2003-10-03 2003-11-05 Ncc Technology Ventures Pte Lt Materials and methods relating to breast cancer classification
EP1880335A1 (en) * 2005-05-13 2008-01-23 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
US20070218512A1 (en) * 2006-02-28 2007-09-20 Alex Strongin Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management

Also Published As

Publication number Publication date
US20110306507A1 (en) 2011-12-15
EP2188385A2 (en) 2010-05-26
AU2008314009A1 (en) 2009-04-23
WO2009049966A3 (en) 2009-07-09
CA2695814A1 (en) 2009-04-23
JP2010537658A (ja) 2010-12-09
WO2009049966A2 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
BRPI0820914A2 (pt) Kit para teste de células e método
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
EP2504454A4 (en) ELITE EVENT EE-GM3 AND METHOD AND KITS FOR IDENTIFYING SUCH AN EVENT IN BIOLOGICAL SAMPLES
HK1216189A1 (zh) 脂肪肝疾病的生物標誌物及其用法
BRPI0814362A2 (pt) Estrutura de interligação para dispositivo eletroquímico de alta temperatura e método para fazer o mesmo
BRPI0817031A2 (pt) kit de diagnóstico e método para prognóstico de cancro em sujeitos mamíferos
EP2234916A4 (en) UNIVERSAL SPECIMEN PREPARATION SYSTEM AND ITS USE IN AN INTEGRATED ANALYSIS SYSTEM
CR10667A (es) Compositions and methods for diagnosing and treating cancer
IL185477A0 (en) Diagnostic methods and systems based on urine analysis
DK2208070T3 (da) Diagnostisk prædiktiv og prognostisk test for cancer
BRPI0718857A2 (pt) Método e equipamento para determinação de posição com informações de órbita sps estendida
EP2118794A4 (en) SYSTEM AND METHOD FOR SELF-VERIFYING LABORATORY TEST RESULTS
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
EP2181410A4 (en) METHOD AND SYSTEM FOR PERFORMING ISOGEOMETRIC ANALYSIS BASED ON T-SPLINE
BRPI0716163A2 (pt) mÉtodos e kits para detectar fluido cÉrebro-espinhal em uma amostra
BRPI0820980A2 (pt) Composições e métodos para detecção de tiabs
BRPI0814330A2 (pt) métodos e kits cirúrgicos
BRPI0912210A2 (pt) dispositivo para medição e gerenciamento de analito e métodos associados
BRPI0916613A2 (pt) exibições antecipadas de navegação primária para abordagens precisas e não precisas
BRPI0911513A2 (pt) métodos e agentes para coleta de células tronco da medula óssea funcionais in vivo com alta eficiência
BRPI0820885A2 (pt) Composições e métodos para diagnóstico precoce de gravidez
BRPI1013671A2 (pt) método para o diagnóstico de endometriose e kit de diagnóstico para endometriose
BR112012027574A2 (pt) aparelho e kit de encapsulação de pelo menos um composto para uso terapêutico e/ou em diagnóstico em eritrócitos
BRPI0820721A2 (pt) Reagentes e métodos para detectar analitos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]